Dana Leach
7Patents
6h-index
13Co-inventors
56Inventor score
Filing activity: Dec 4, 1995 → Aug 11, 2005
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5811097A | Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling | Emerging Cross-Sectional Technologies | 214 | Expired |
| US6051227A | Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling | Chemistry; Metallurgy | 135 | Expired |
| US5855887A | Blockade of lymphocyte down-regulation associated with CTLA-4 signaling | Chemistry; Metallurgy | 79 | Expired |
| US7005498B1 | Methods for therapeutic vaccination | Emerging Cross-Sectional Technologies | 23 | Expired |
| US7229628B1 | Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling | Chemistry; Metallurgy | 21 | Expired |
| US7807441B2 | Methods for therapeutic vaccination | Emerging Cross-Sectional Technologies | 11 | Active |
| US7820633B2 | Methods for therapeutic vaccination | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.